A Randomised, Double-blind, Placebo-controlled, Multicentre Trial Exploring the Efficacy and Safety of Intra-nasal Administration of FE 202767 in Increasing Milk Production in Maternal Subjects With Preterm Delivery and Inadequate Milk Production
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 18 Oct 2017
At a glance
- Drugs Merotocin (Primary)
- Indications Lactation failure
- Focus Therapeutic Use
- Acronyms Mermaid
- Sponsors Ferring Pharmaceuticals
- 13 Oct 2017 Planned End Date changed from 1 Jun 2018 to 1 Oct 2019.
- 13 Oct 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Oct 2019.
- 13 Oct 2017 Planned initiation date changed from 20 Nov 2017 to 30 Jun 2018.